Key statistics dashboard for Jaguar Health, Inc. (JAGX). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Jaguar Health, Inc., a commercial-stage pharmaceutical firm, specializes in developing prescription therapies for both human and animal patients afflicted by gastrointestinal ailments, particularly chronic and severe diarrhea. Its operations are structured into two distinct divisions: Human Health and Animal Health.
Stock Data
| Price | $0.23 |
| Market Cap | $0M |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.00 |
| Price / Book | 0.03 |
| P/S | 0.00 |
| P/FCF | -0.00 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 82.31% |
| EBIT Margin | -151.47% |
| EBITDA Margin | -144.11% |
| Operating Margin | -90.22% |
| Net Margin | -131.76% |
Financial Health
| Current Ratio | 0.69 |
| Quick Ratio | 0.40 |
| Cash Ratio | 0.26 |
| Debt / Equity | 2.52 |
| Debt / Assets | 48.70% |
| Interest Coverage | -28.98 |
Per-Share Data
| Revenue per share | 34.38 |
| Book Value per share | 6.08 |
| Cash per share | 8.14 |
| FCF per share | -8.36 |
| Tangible Book Value per share | -12.56 |
| Dividend per share | 0.00 |
Related companies: BDRX · CANF · CLDI · CNSP · GNPX · GRI · INM
Explore sector: Healthcare · Biotechnology
More sections of JAGX: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks